Stay updated on Carfilzomib Combo for Myeloma Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.

Latest updates to the Carfilzomib Combo for Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded 'Multiple myeloma' as a topic and linked 'MedlinePlus Genetics' as a related topic. Updated site revision to v3.5.0 and removed v3.4.3.SummaryDifference0.2%

- Check21 days agoChange DetectedRevision: v3.4.3 was added; references to 'Multiple Myeloma' and 'MedlinePlus Genetics' related topics were removed.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics.SummaryDifference0.1%

- Check49 days agoChange DetectedA new site revision (v3.4.2) was added and an older funding/operational status notice (v3.4.1) was removed; no core study details appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedA government-funding notice banner was added and the site was updated to revision v3.4.1; the study details page content remains unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a glossary display, a new QC status line 'Last Update Submitted that Met QC Criteria', and a 'No FEAR Act Data' label, along with updating the revision to v3.4.0. The older 'Last Update Submitted that met QC Criteria', lowercase 'No FEAR Act data', and the previous 'Revision: v3.3.4' text have been removed.SummaryDifference0.2%

Stay in the know with updates to Carfilzomib Combo for Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.